Chelsey Penrod Hickman
🏛️ Revolving DoorFormer Government Positions:
CoS, Rep. Kay Granger; LA Sen. Larry Craig
CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
🤖
AI Overview
Chelsey Penrod Hickman has appeared in 1,550 federal lobbying filings at Winning Strategies Washington, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 33 policy areas.
1,550
Total Filings
1
Firms
50
Clients
33
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 256 | 26 |
| 2019 | 187 | 27 |
| 2020 | 266 | 39 |
| 2021 | 213 | 32 |
| 2022 | 206 | 25 |
| 2023 | 163 | 25 |
| 2024 | 125 | 15 |
| 2025 | 134 | 18 |
Firms
Winning Strategies Washington1550 filings
Top Clients
Kaleo115 filings
National Alliance on Mental Illness86 filings
National Troopers Coalition81 filings
Windlift77 filings
Avx Aircraft Company55 filings
Diabetes Patient Advocacy Coalition55 filings
Cleanslate Centers INC43 filings
Beth Medrash Govoha42 filings
Trauma Center Association of America41 filings
Frontier Polymers38 filings
Deborah Heart and Lung Center35 filings
Seton Hall University34 filings
I Am Als33 filings
Colorectal Cancer Coalition32 filings
Ocean Conservancy, INC.31 filings
Marotta Controls30 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Foreign Governments Are Lobbying Congress
1,000+ foreign entities from 50+ countries lobby the US government.
The 22,000% ROI
When lobbying spending yields outsized returns.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.